Sep 06, 2023 / 04:45PM GMT
Yanan Zhu - Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
Great. Thanks, everyone, for being here. My name is Yanan Zhu, and I'm one of the biotech analysts here at Wells Fargo. We're privileged to have the management team of Ionis Pharmaceuticals with us today for a fireside chat. And with me here are Beth Hougen, CFO; and Onaiza Cadoret, Chief Global Product Strategy and Operations Officer. Thanks, Beth and thanks, Onaiza, for being here.
Elizabeth L. Hougen - Ionis Pharmaceuticals, Inc. - Executive VP of Finance & CFO
Of course.
Onaiza Cadoret-Manier - Ionis Pharmaceuticals, Inc. - Executive VP, Chief Global Product Strategy & Operations Officer
Thank you.
Questions and Answers:
Yanan Zhu - Wells Fargo Securities, LLC, Research Division - Senior Equity AnalystSo a lot to talk about. I hope -- I was wondering if we can dive right in, into the eplontersen polyneuropathy U.S. approval and launch. I have a set of
Trustpilot
